Related Experiment Video
Updated: Jun 3, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Management of Diuretic Induced Hypokalemia in Elderly Hypertensives
Bertram Pitt1, Christopher S Wilcox2
1Department of Cardiology, University of Michigan, Ann Arbor (B.P.).
Insights
Hypokalemia, low potassium, is common in elderly hypertensive patients on diuretics, increasing risks. This review highlights unique brain mechanisms that necessitate specific strategies for prevention and treatment in this population.
Area of Science:
- Gerontology
- Cardiology
- Nephrology
Background:
- Hypokalemia is prevalent in elderly hypertensive individuals using diuretics.
- This electrolyte imbalance exacerbates cardiovascular, cerebrovascular, and renal risks.
Purpose of the Study:
- To review evidence on the specific risks of diuretic-induced hypokalemia in elderly hypertensives.
- To explore the unique neurobiological mechanisms involved.
- To inform preferred strategies for hypokalemia management in this cohort.
Main Methods:
- Literature review of existing studies and evidence.
- Analysis of the role of aldosterone and mineralocorticosteroid receptors.
- Examination of cortisol's interaction with these receptors in the brain.
Main Results:
- Diuretic-induced hypokalemia increases aldosterone penetration into the brain.
- Enhanced mineralocorticosteroid receptor signaling and cortisol activation contribute to heightened risk.
- These factors create a unique pathophysiological profile in affected patients.
Conclusions:
- Elderly hypertensives with diuretic-induced hypokalemia face distinct risks due to central mineralocorticoid excess.
- Management strategies must consider these specific brain-related mechanisms.
- Tailored approaches are crucial for preventing and treating hypokalemia in this vulnerable group.
Abstract:
Hypokalemia occurs frequently in elderly hypertensives treated with diuretics, where it enhances cardiovascular, cerebrovascular, and renal risk. Literature Review. We review the evidence that hypertensive patients with diuretic-induced hypokalemia are at special risk from increased penetration of aldosterone into the brain, enhanced mineralocorticosteroid receptor and postreceptor signaling, and enhanced activation of the mineralocorticosteroid receptor by cortisol. This leads to unique considerations for the preferred strategy to prevent or treat hypokalemia in this vulnerable group.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Diuretics
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Antihypertensive Drugs: Action of Diuretics